LRP1B and hepatocellular carcinoma: Here, we also deeply investigated the immune cell infiltration in different groups of HCC patients distinguished by LRP1B mutation, where differences in the proportion of immune cell infiltration might be an intrinsic feature of individual differences receiving immunotherapy.